Oral antidiabetic therapy with delayed-action glibenclamide and phenformin in fixed combination
Beringer, A.
Minerva Medica 65(60): 3127-3139
1974
ISSN/ISBN: 0026-4806 PMID: 4214043 Document Number: 71582
Document emailed within 1 workday
Related Documents
Palmieri, G.; Alkabes, M. 1977: Treatment of overweight diabetics with a combination of glibenclamide and phenformin La Clinica Terapeutica 81(6): 537-546Bhatt, S.D.; Gill, T.S. 1979: Effect of a new oral antidiabetic drug HB 419 (Glibenclamide) on the plasma glucose and islet histology of two poikilotherms: Clarias batrachus and Uromastix hardwicki Indian Journal of Experimental Biology 17(10): 1122-1126
Gottmann-Lückerath, I. 1983: Clinico-experimental study on the start of the pharmacological action of an oral classical antihistaminic without and with delayed-action effect on the length of effect of the delayed-action type Die Medizinische Welt 34(18): 548-551
Gervasini, A. 1974: Therapeutic activity of a glibenclamide-phenformin association in maturity-onset diabetes Minerva Medica 65(73): 3835-3842
Haslbeck, M. 1979: New aspects of therapy with oral antidiabetic agents Wiener Medizinische Wochenschrift 199(24): 689-695
Malesker, M.A.; Hilleman, D.E. 2010: Comparison of amlodipine/valsartan fixed-dose combination therapy and conventional therapy Managed Care 19(7): 36-42
Stein Gold, L.; Kircik, L.H.; Pariser, D.; Sugarman, J.L.; Lin, T.; Kang, R.; Pillai, R. 2018: Rapid Onset of Action in Patients with Moderate-to-Severe Plaque Psoriasis with Halobetasol 0.01%/Tazarotene 0.045% Fixed Combination Journal of Drugs in Dermatology: Jdd 17(8): 863-868
Schmitt, E.W.; Nijssen, J. 1978: Glibornuride--field study on an oral antidiabetic agent. Results of therapy with gluboride in a large number of patients Die Medizinische Welt 29(29-30): 1170-1174
Kuritzky, L. 2006: Addition of basal insulin to oral antidiabetic agents: a goal-directed approach to type 2 diabetes therapy Medgenmed: Medscape General Medicine 8(4): 34
Schrader, J. 1998: Hypertension: pro and contra fixed combination therapy. Pro Fortschritte der Medizin 116(14): 37-38
Dieterich, H.A.; Messer, W.; Jaehnchen, E. 1984: Plasma concentrations of theophylline and quinine in healthy volunteers following oral administration of a fixed drug combination Arzneimittel-Forschung 34(4): 520-522
Teuscher, U.; Strub, J.R. 1982: The combination of orthodontics and fixed prosthetics in interdisciplinary therapy International Journal of Periodontics and Restorative Dentistry 2(1): 47-64
Vaïsse, B.; Silhol, F.; Bouchlagen, K.; Gallois, H.; Poggi, L. 1999: New requirements in the primary treatment of arterial hypertension: why do we need fixed low-dose combination therapy? Presse Medicale 28(9): 500-506
Salvadeo, A.; Villa, G.; Segagni, S.; Moroni, G.; Poggio, F. 1988: Validity of a fixed atenolol/hydrochlorothiazide/amiloride combination (100/25/2.5 mg) in the therapy of essential arterial hypertension Minerva Cardioangiologica 36(3): 109-113
Einecke, D. 2012: Compliance promoting hypertension therapy. with early fixed combination more rapid target reading MMW Fortschritte der Medizin 154(7): 29
Webster, G.F. 2011: Evidence-based review: fixed-combination therapy and topical retinoids in the treatment of acne Journal of Drugs in Dermatology: Jdd 10(6): 636-644
Turchetti, G.; Di Veroli, C. 1981: Delayed-action clonidine capsules in the therapy of arterial hypertension La Clinica Terapeutica 97(6): 605-611
Zaka-Ur-Rehman, Z.; Jamshaid, M.; Chaudhry, A. 2008: Clinical evaluation and monitoring of adverse effects for fixed multidose combination against single drug therapy in pulmonary tuberculosis patients Pakistan Journal of Pharmaceutical Sciences 21(2): 185-194
Aliyu, M.H.; Blevins, M.; Parrish, D.D.; Megazzini, K.M.; Gebi, U.I.; Muhammad, M.Y.; Ahmed, M.L.; Hassan, A.; Shepherd, B.E.; Vermund, S.H.; Wester, C.W. 2014: Risk factors for delayed initiation of combination antiretroviral therapy in rural north central Nigeria Journal of Acquired Immune Deficiency Syndromes 65(2): E41-E49
Fariello, R.; Alicandri, C.; Boni, E.; Montini, E.; Zaninelli, A.; Agabiti-Rosei, E.; Motolese, M.; Muiesan, G. 1984: Continuous 24-hour registration of intra-arterial pressure in basal states and during therapy with a fixed slow-release oxprenolol-chlorthalidone combination, administered once a day Giornale Italiano di Cardiologia 14(2): 121-126